recombinant Str1 (rStr1). Scp2 cells grow as an epithelial
riphery (Figure 2A). Thus, induction of Str1 expression triggered EMT and rendered the cells tumorigenic and invasive in vivo.
When Tet was withheld from the drinking water for 12 days after injecting uninduced p2S10 cells and then replaced for the remaining 4.3 weeks, tumor formation was still seen, albeit at a lower rate than when Tet was continuously absent ( Figure 2B ). This suggests that once tumorigenicity is achieved, it would not be blocked by repressing Str1 expression. To test this, we induced Str1 expression in culture for 2 months in p2S10 and To examine the long-term effect of Str1 on normal mamand loss of E-cadherin, and acquisition of the ability to form anchorage-independent colonies in agar and mary epithelial cells, we used WAP-Str1 transgenic mice. We had previously observed precocious lobuloalinvade Matrigel (Lochter et al., 1997) . For the present study, we used two clones with regulated Str1 expresveolar development in 3-to 10-week-old WAP-Str1 transgenic mice (Sympson et al., 1994) and an altered sion (p2S7 and p2S10), a nonexpressing clone (p2S3), and parental Scp2 cells. When Scp2 cells and Str1-reactive stroma in 2-to 4-month-old mice (Thomasset et al., 1998). Here we found that 6-to 24-month-old transfected cells grown in the presence of Tet were injected into surgically cleared (gland-free) mammary fat transgenic mice exhibited mammary abnormalities, premalignant lesions, and malignancies (Figures 3 and 4) . Of pads of scid/scid mice, they grew and formed relatively normal duct-like and pseudoglandular structures if the 163 mice from five independent transgenic lines (median age 18 months), 77% had moderate or severe fibrosis mice were given Tet in their drinking water (Figures 2A a  and 2A b ) . These structures had cytokeratin-8-positive, (collagen and fibroblast accumulation with adipocyte loss), 64% had moderate or severe hyperplasia (epithevimentin-negative luminal cells but lacked smooth muscle actin-positive myoepithelial cells that normally surlial cell accumulation), 53% had lymphocytic infiltrates, 20% had dysplasias (atypical proliferative lesions) or round luminal epithelium (Figures 2A c and 2A d ) . The ductal structures did not branch, which is consistent with ductal carcinoma in situ, and 7.4% developed mammary carcinomas. the lack of myoepithelial cells that produce epimorphin, a morphogen required for branching (Hirai et al., 1998) .
The incidence of the various lesions was 1.2-to 1.9-fold higher in parous mice than in virgin mice, and hyperThis growth pattern persisted for at least 13 weeks. However, when Str1 expression was induced in vivo by plastic and fibrotic changes were generally more severe in parous animals. Whereas increases in incidence and withholding Tet from the drinking water, the p2S10 cells formed small tumors in 5 of 18 injected sites by 6 weeks severity would be expected given the pregnancy-driven nature of the WAP promoter, their modesty may reflect ( Figure 2B ). The tumors were composed largely of vimentin-positive and cytokeratin-negative spindle-shaped the fact that the promoter is minimally active during each estrus cycle, so that parity only slightly increases (mesenchymal-like) cells and were invasive at their pe- lifetime Str1 exposure. Indeed, even low transgene expression during puberty causes increased ductal branching and precocious lobuloalveolar development (Sympson et al., 1994), thus increasing the number of potential target cells that are "at risk" over an extended period of time. Average tumor latency was 18.7 months, with the first tumor appearing in a 6-month-old parous mouse. The hyperplastic and fibrotic lesions tended to be more severe in older animals, and the incidence of hyperplasia increased from 46% at 6 months to 78% at 2 years of age. These data are consistent with a model of multistage neoplastic progression induced by Str1 expression.
Mammary carcinomas were seen in mice from three different founders (fewer than ten mice were studied in the other two lines). Nine of the tumors were moderately carrying both Str1 and TIMP1 transgenes had mild mamWe also isolated two sublines of Str1 transgenic mice mary hyperplasias, whereas 8 of 11 mice (73%) carrying in which expression of the transgene was silenced and the Str1 transgene alone had moderate to severe hypercould not be detected by RT-PCR, presumably due to plasias. A similar frequency (66%) was seen in the cohort transgene methylation as determined by altered sensiof 100 WAP-Str1 females from the same transgenic tivity to restriction endonucleases. The nonexpressing founder (M2-5). Mice carrying only the TIMP1 transgene transgenic mice (median age 13 months) also showed had a slightly altered involution phenotype but were a low incidence of mild lesions (Figure 3 ). These data otherwise normal. Nontransgenic littermates had enindicate that expression of the Str1 transgene is required tirely normal mammary glands. These data indicate that to promote neoplastic progression.
active Str1 is required for mammary lesions to develop.
TIMP1 Inhibits the Development of Mammary Str1 Expression Promotes Stereotyped Hyperplasias in Str1 Transgenic Mice
Genomic Changes If the induction of neoplasia by Str1 is due to its proteoBecause Str1 acts extracellularly, we wanted to deterlytic activity, then overexpression of its endogenous inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP1), mine if tumorigenicity was accompanied by genomic 
